One Health Preparedness and Response: Translating Surveillance of Emerging Zoonotic Diseases into Biotechnology

11:05 AM - 11:50 AM (EDT), Monday, June 14, 2021
Search General Info
Search Education
Search Partnering Companies

One Health, or the concept that animal, human, and environmental health are interconnected, has been made readily apparent by the recent COVID-19 pandemic. The World Health Organization estimates that more than 60% of human diseases are zoonotic and that 75% of diseases discovered over the past decade originate in animals. Efforts such as the US Agency for International Development (USAID) PREDICT program have worked over the past decade to increase our knowledge of potential viral threats by identifying viruses that may cause global public health emergencies. How does this increased knowledge translate into biotechnology solutions to ensure we are prepared for zoonotic threats to human health? Hear from public health experts and company leaders about how the biotechnology industry can play a powerful role in finding innovative solutions to macro-level, cross-sectional One Health problems. 

Moderator
photo
Senior Policy Advisor & Senior Scientist
EcoHealth Alliance
Speakers
photo
Captain, U.S. Public Health Service, Director, One Health Office
National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention
photo
Co-Founder & Chief Executive Officer
BioFeyn
photo
SVP
Zoetis
photo
Senior Policy Advisor & Senior Scientist
EcoHealth Alliance
photo
President & CEO
SAB Biotherapeutics